Industry Insights

  1. Takeda's Green Approach To IG Purification And Filling 8/14/2023

    To secure its spot as a 2023 ISPE Facility of the Year Awards winner, Takeda Lessines made some big moves including building a wastewater treatment center on-site in Belgium and installing 8,000 solar panels. This Q&A is part of a feature series on select FOYA winners.

  2. Evaluating The Constraints Of Long-Term Ultracold Storage 9/28/2021

    Many of the countless biopharma freezers don’t meet the requirements of big pharma or small biotech. This comparison of cold storage options will help you make sound decisions for ultracold storage. 

  3. The Detection Of Endotoxins Via The LAL Test, The Chromogenic Method

    Previous articles in this series covered the gelation and turbidimetric methods used in the Limulus Amebocyte Lysate test for bacterial endotoxins. Here, we focus on the chromogenic method.

  4. Navigating Data Management Requirements For Sterile Manufacturing 6/11/2025

    Contamination control strategies are rooted in representative and trustworthy data, but companies still do a poor job at maximizing their use of data to optimize.

  5. Guidelines For Defining A Control Strategy Framework For Accelerated mAb Programs 11/6/2025

    This article assembles an industrywide “platform” knowledge base on the impact of parameters across unit operations in a standard mAb process. 

  6. De-Risking Visible Particles Through Component Selection

    Explore a summary of the FDA’s recent draft guidance “Inspection of Injectable Products for Visible Particulates” and how it applies to components.

  7. COVID-19's Impact On Availability Of Drugs And API From India And China 4/23/2020

    COVID-19 has caused an increase in demand for APIs and drugs; those used as antimalarials are seeing the highest demand, followed by bronchodilators, antibiotics, and antivirals. This article reviews the drugs and API in demand globally, with assessments of their supply status in India and China.

  8. Extracellular Vesicle Production, Characterization, And Quantification Methods 12/21/2022

    While extracellular vesicles represent significant opportunity for the biologics space, researchers are still building a foundation of knowledge surrounding their biology, application, and ultimate value.

  9. Developing New Medicines Through Artificial Intelligence 10/16/2024

    Embrace the future of drug development by leveraging AI and innovative protein synthesis technologies to accelerate the creation of effective therapies and transform patient outcomes.

  10. Tackling The Challenges Of Biologics Development And Manufacturing

    Biologics are a growing, promising solution to address unmet medical needs. It is critical to have the right manufacturing partner to minimize challenges as a therapy moves from discovery to commercialization.